Recent changes in influenza epidemiology and vaccination recommendations

Journal of Family Practice

Volumn 54, Issue SUPPL. 1, 2005, Pages

  Zimmerman, Richard Kent ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

ABDOMINAL PAIN; ACUTE RESPIRATORY TRACT DISEASE; ANAPHYLAXIS; ASTHMA; AVIAN INFLUENZA; BACTERIAL INFECTION; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; COUGHING; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; ENCEPHALITIS; FEVER; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LABORATORY TEST; MALAISE; MEDICAL PRACTICE; MYALGIA; NOSE CONGESTION; OTITIS MEDIA; PNEUMONIA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REVIEW; REYE SYNDROME; RHINORRHEA; SKIN MANIFESTATION; SORE THROAT; VIRUS CULTURE; VIRUS TRANSMISSION; VOMITING; WHEEZING;

AGE FACTORS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 12144268413     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Thompson W, Shay D, Weintraub E, Brammer L, Anderson L, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340.
3. Neuzil KM, Wright PF, Mitchel EF, Griffin MR. Burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856-864.
4. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2004;53:743]. MMWR Morb Mortal Wkly Rep. 2004;53:1-39.
5. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalization, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
6. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
7. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499-505.
8. Sullivan KM, Monto AS, Longini LM, Jr. Estimates of the US health impact of influenza. Am J Public Health. 1993;83:1712-1716.
9. Strassburg MA, Greenland S, Sorvillo FJ, Lieb LE, Habel LA. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine. 1986;4:38-44.
10. Meiklejohn G, Hall H. Unusual outbreak of influenza A in a Wyoming nursing home. J Am Geriatr Soc. 1987;35:742-746.
11. Goodman RA, Orenstein WA, Munro TF, Smith SC, Sikes RK. Impact of influenza A in a nursing home. JAMA. 1982;247:1451-1453.
12. Glezen WP. Consideration of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis. 1980;2:408-420.
13. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16:1065-1068.
14. Glezen WP, Couch RB, Taber LH, et al. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol. 1980;111:13-22.
15. Monto AS, Davenport FM, Napier JA, Francis T, Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis. 1970;122:16-25.
16. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993;168:881-887.
17. Reichert TA, Sugaya N, Fedson DS, Giezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344:889-896.
18. Pickering LD, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2003.
19. Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol. 2000;38:839-845.
20. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001;20:733-740.
21. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1991;163:300-304.
22. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children. JAMA. 2003;290:1608-1616.
23. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995;333:889-893.
24. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization from pneumonia in the elderly. Am J Epidemiol. 1992;13:296-307.
25. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccine in Manitoba [published correction appears in JAMA. 1994;271:1578]. JAMA. 1993;270:1956-1961.
26. Barker WH, Mullooly JP. Effectiveness of inactivated influenza vaccine among non-institutionalized elderly persons. In: Options for the Control of Influenza. New York, NY: Alan R. Liss, Inc; 1986;169-182.
27. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
28. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661-1665.
29. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784.
30. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000;136:168-175.
31. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus [sic] vaccine in children. N Engl J Med. 1998;338:1405-1412.
32. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137-144.
33. Treanor J, Kotloff K, Betts RF, et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine. 2000;18:899-906.
34. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: cost effectiveness and public policy. JAMA. 1983;249:3189-3195.
35. Centers for Disease Control and Prevention. Final results: Medicare influenza vaccine demonstration - selected states, 1988-1992. MMWR Morb Mortal Wkly Rep. 1993;42:601-604.
36. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis. 1999;5;659-671.
37. Cohen GM, Nettleman MD. Economic impact of influenza vaccination in preschool children. Pediatrics. 2000;106:973-970.
38. White T, Lavoie S, Nettleman MD. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics. 1999;103:1-5.
39. Luce BR, Zangwill K, Palmer CS, et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics. 2001;108:e24-e38.
40. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA. 1990;307:988-990.
41. American Lung Association Asthma Clinical Research Centers: Safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med. 2001;345:1529-1536.
42. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979;110:105-123.
43. Murphy KR, Strunk RC. Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. J Pediatr. 1985;106:931-933.
44. Zimmerman RK, Hoberman A, Nowalk MP, et al. Feasibility of influenza immunization for inner-city children aged 6-23 months. Am J Prev Med. 2004;27:397-403.
45. Ohrt CK, McKinney WP. Achieving compliance with influenza immunization of medical house staff and students: a randomized controlled trial. JAMA. 1992;267:1377-1380.
46. Weingarten S, Riedinger M, Bolton LB, Miles P, Ault M. Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control. 1989;17:202-207.
47. National Foundation for Infectious Diseases. Influenza Immunization Among Health Care Workers. 2004. Available at: www.nfid.org/publications/ calltoaction.pdf. Accessed November 30, 2004.
48. Potter J, Stott DJ, Elder AG, O'Donnell B, Knight PV, Carman WF. Influenza vaccination of health care workers in long-term care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1-6.
49. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93-97.